Michael Malone M.D., Ali Ward RN, Office Manager

Slides:



Advertisements
Similar presentations
Critical Airway Management: In a Teaching Institution Manu Malhotra & Jennifer Ritz.
Advertisements

Taking Research and Development to the Clinic: Issues for Physicians AAAS/FDLI Colloquium I Diagnostics and Diagnoses Paths to Personalized Medicine Howard.
Title slide Georgia Hospital Engagement Network Healthcare Acquired Condition Affinity Group June 19, 2013 Presenter: Dr. Teresa Pounds, PharmD, BCNSP.
Introduction 3.03 Understand support services Introduction.
Cross-Canada Collaboration to Promote Evidence-Based Use of Anticoagulants CADTH SYMPOSIUM APRIL 14, 2015.
Engaging the C-suite to Advance Pharmacy Practice Providing quality patient care through progressive pharmacy practice Evaluation of Unit-based Pharmacy.
Implementation of local guideline by interactive workshop improves anticoagulation therapy and patient safety Puhakka J, Helsinki Health Centre, GP Suvanto.
Interprofessional Team Rounding: A Value Added Innovative Approach to Align the Educational and Clinical Mission in Health Care Systems Mukta Panda, MD,
Interdisciplinary Collaboration: Challenges and Successes Michael S. Neal Scientific Director, ONE Fertility, 3210 Harvester Rd. Burlington, Ontario
Antiplatelet or Anticoagulant: Do They Have the same Efficacy? University of Central Florida Deborah Andrews RN, BSN.
CPRS/Pharmacy Laboratory Monitoring Project
The Emergency Pharmacist (EPh): A Safety Measure in Emergency Medicine Supported by The Agency for Healthcare Research and Quality, Partnerships in Patient.
Introduction to Healthcare and Public Health in the US Delivering Healthcare (Part 2) Lecture e This material (Comp1_Unit3e) was developed by Oregon Health.
Preventing Surgical Complications Prevent Harm from High Alert Medication- Anticoagulants in Primary Care Insert Date here Presenter:
Richardia Gibbs-Hook Julie Walker.  Patient satisfaction surveys are one tool by which quality and safety are measured. ◦ Hospital Consumer Assessment.
Plan Your Road Trip: An Algorithm for Safety Presented by: Rebecca Shutts BSN Kathleen Carey MSN, CNS Kevin Hamel RN.
New Insights on Warfarin: How CYP 2C9 & VKORC1 Information May Improve Benefit-Risk Ratio Brian F. Gage, MD, MSc Associate Professor of Medicine, Washington.
DVT Prevention and Anticoagulant Management
Beyond ePrescribing Factors Influencing Patient Safety in Medical Group Practices - September 26 th, 2007 AHRQ 2007: Improving Healthcare, Improving Live.
Anticoagulants Reducing the risk Amanda Powell & Sue Wooller May 2014.
P13-P14: Results of the survey amongst critical care physicians and nurses on the knowledge of fluid management and hemodynamic monitoring November 2013.
UMASS Memorial Anticoagulation Center Staffing, Budgets, Reimbursement Pamela Burgwinkle APRN-BC,CACP Presented November 4, 2008.
Confidential: Quality Improvement Material Reducing Clotting Events for Post-Surgical Orthopedic Patients Loyola Anticoagulation Clinic Spring 2009.
Impact of Multidisciplinary Team Care on Older People with Polypharmacy Liang-Kung Chen Center for Geriatrics and Gerontology Taipei Veterans General Hospital.
Rhythm and Rate Control for Atrial Fibrillation Tom Wallace, MD Cardiac Electrophysiology CHI St. Vincent Heart Clinic Arkansas.
Warfarin-Specific Medication Charts Do they have a place in Aged Care Facilities? Margaret Jordan a,b Judy Mullan a, Victoria Traynor a a. University of.
A Multidisciplinary Leadership Model in a Community Health Center Greg Thesing, MD November 2014.
Implementing Nurse-driven protocols that leads to improved team-based care in a PCMH practice Mathew Devine, DO Michael Mendoza, MD Loron Oster, RN Nikki.
Establishment of An Economically Viable Comprehensive Multidisciplinary Anticoagulation Program In An Academic-Based Residency Lilika White MD, Andrew.
The Management of AF Warfarin New anticoagulants 16 Sept 2011.
Date of download: 7/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Transition of Patients From Blinded Study Drug to.
Response to An Initial Dose of Warfarin in Thai Patients Undergoing Long-Term Anticoagulant Therapy Weerayuth Saelim R.Ph. 2 nd year Pharmacy resident.
Impact of Integrating Family Medicine and Pharmacy in an Interdisciplinary Anti-Coagulation Program B. Timothy Kodsi M.D., Michael Machek M.D., Keiran.
1. Forming Care Partnerships Lessons Learned 2 Our Call to Action Virtually all of our residents experience transitions in care Care coordination between.
GIFT: Genetics Informatics Trial of Warfarin
Nguyen Ngoc Tu1,2, Marie-Christine Morel-Kopp3, Chris Ward 3, Robert G
Creighton University College of Nursing, Omaha, NE
Warfarin pretest Joshua Steinberg MD.
Teams and Teamwork Introduction
BUILDING INTEGRATED HEALTH SERVICE DELIVERY NETWORKS
3.03 Understand support services Introduction
Education program ( system). Education program ( system)
Collaborative residency training in Kenya and Ethiopia
Claudia Beals, MD John Detesco Erdal Sarac, MD FACP FASN
Implementation Process
Medication Reconciliation and Reducing Adverse Drug Events
Lilika White MD, Andrew Hwang PharmD, George Samraj, MD
What Are Clinical Trials?
STUDENT POSTER EXAMPLE
PARTNERSHIPS WITH CLINICAL SETTINGS: ROLES AND RESPONSIBILITIES OF NURSE EDUCATORS – Chapter 9 –
Integrative Medicine Approach to Diabetes Group Visits within a Patient Centered Medical Home Krishna Desai, MD; Scott Bragg, PharmD; Sarah Winter, PharmD;
3.03 Understand support services Introduction
The Nursing Process and Pharmacology Jeanelle F. Jimenez RN, BSN, CCRN
Access to NOAC Therapy:
UNT Health Clinical Pharmacist Services
Warfarin Prescribing.
Surveying the Safety of NOACs in the Real World
In+Care 04 – Viral Load Suppression Project
3.03 Understand support services Introduction
Access to NOAC Therapy:
Reversal Strategies for VKA: Truths and Misconceptions
The first screen used is designed to document symptom pursuit and review the complications of anticoagulation therapy. In addition this screen is where.
Barriers to Safe Transitions
Collecting health equity info – in the shoes of patients and providers
Assessing Atrial Fibrillation: Real-World Data vs Clinical Trials
3.03 Understand support services Introduction
3.03 Understand support services Introduction
3.03 Understand support services Introduction
3.03 Understand support services Introduction
Jaque Goudreault, University of New Hampshire, Senior Nursing Student
Presentation transcript:

Michael Malone M.D., Ali Ward RN, Office Manager Improving Coumadin Management Through a Multidisciplinary Quality Improvement Project Michael Malone M.D., Ali Ward RN, Office Manager Penn State Hershey Department of Family and Community Medicine METHODS:   A multidisciplinary approach was taken to improve INR values. 1. Physicians received education and algorithms were made readily available throughout the clinical site. 2. Patient who would benefit from NOACS were identified by providers and a care management system assisted with transition of these patients. 3. Staff resources were used to follow-up with patients who were overdue for their INR lab, but had not had it completed. 4. Attribution lists were appropriately updated/corrected. INTRODUCTION   Coumadin management, measured by percentage of patients at goal INR, in patients on anticoagulation is an important quality and safety measure. In this session, we describe the QI project we implemented to improve Coumadin management at our clinical site. PURPOSE: Our goal was to improve the percentage of INR values at goal range for patients on anticoagulation from 60% to 66% .  RESULTS:   We surpassed our goal of 66% of Coumadin patients in range to a persistent value of approximately 70% of patients in range. There was a dip in results that may be related to lack a lack of continuous process implementation. REFERENCES Tideman P, Tirimacco R, St John A, Roberts G. How to manage warfarin therapy. Aust Prescr. 2015  CONCLUSION: Implementation of a QI project to improve Coumadin management can be successful through an interdisciplinary approach using multiple interventions. Gage BF, Eby C, Johnson JA, et al. Use of Pharmacogenetic and Clinical Factors to Predict the Therapeutic Dose of Warfarin. Clinical Pharmacology and Therapeutics. 2008 .